WDR41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.945700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.435040E-03
Normal-vs-Stage2
3.429900E-02
Normal-vs-Stage3
4.330400E-02
Normal-vs-Stage4
5.249000E-01
Stage1-vs-Stage2
7.943000E-01
Stage1-vs-Stage3
3.685200E-01
Stage1-vs-Stage4
3.015200E-01
Stage2-vs-Stage3
1.664980E-01
Stage2-vs-Stage4
1.497160E-01
Stage3-vs-Stage4
1.431820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.302200E-02
Normal-vs-AfricanAmerican
1.612220E-01
Normal-vs-Asian
2.062400E-02
Caucasian-vs-AfricanAmerican
4.273000E-01
Caucasian-vs-Asian
7.308000E-02
AfricanAmerican-vs-Asian
1.233370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.042400E-02
Normal-vs-Female
2.227700E-02
Male-vs-Female
7.742000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.134100E-02
Normal-vs-Age(41-60Yrs)
3.529700E-02
Normal-vs-Age(61-80Yrs)
4.344300E-02
Normal-vs-Age(81-100Yrs)
1.144150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.610200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.113000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.942000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.494450E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.946800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.022000E-03
Normal-vs-Daily Drinker
1.574130E-02
Normal-vs-Weekly Drinker
3.096400E-02
Normal-vs-Occasional Drinker
1.132620E-01
Normal-vs-Social Drinker
8.458400E-02
Non Drinker-vs-Daily Drinker
6.389200E-01
Non Drinker-vs-Weekly Drinker
7.095400E-01
Non Drinker-vs-Occasional Drinker
1.594610E-01
Non Drinker-vs-Social Drinker
6.787600E-02
Daily Drinker-vs-Weekly Drinker
9.822400E-01
Daily Drinker-vs-Occasional Drinker
3.562600E-01
Daily Drinker-vs-Social Drinker
1.875360E-01
Weekly Drinker-vs-Occasional Drinker
4.261200E-01
Weekly Drinker-vs-Social Drinker
2.484600E-01
Occasional Drinker-vs-Social Drinker
7.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.470350E-01
Normal-vs-Grade 2
2.134200E-02
Normal-vs-Grade 3
6.700400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.520400E-03
Grade 1-vs-Grade 3
8.704600E-03
Grade 1-vs-Grade 4
1.470350E-01
Grade 2-vs-Grade 3
6.260000E-01
Grade 2-vs-Grade 4
2.134200E-02
Grade 3-vs-Grade 4
6.700400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.633600E-02
Normal-vs-NonDiabetic
2.288200E-02
Diabetic-vs-NonDiabetic
8.803600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.836490E-02
Normal-vs-NoPancreatitis
3.758200E-02
Pancreatitis-vs-NoPancreatitis
3.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.534100E-02
Normal-vs-N1
3.784400E-02
N0-vs-N1
5.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.064360E-01
Normal-vs-TP53-NonMutant
2.548100E-02
TP53-Mutant-vs-TP53-NonMutant
1.275010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
